Elliot Beimel

Elliot Beimel brings more than 25 years of experience and a keen understanding of the pharmaceutical industry to his role as Vice President, Finance for Ipsen North America.

In his role, he is responsible for the Accounting & Shared Services, Tax, Procurement, Government Pricing Reporting, Forecasting and Financial Planning & Analysis.

Elliot joined Ipsen in 2018 as Senior Director of Financial Planning & Analysis and assumed the additional responsibility of Forecasting in 2020. Prior to joining Ipsen, Elliot spent 18 years with Amgen Inc. based in California and the Netherlands. While at Amgen, Elliot held numerous roles of increasing responsibility across Technical Accounting & SEC Reporting, Corporate Finance, R&D Finance, Internal Audit, and Commercial Finance, most recently serving as Head of Finance for the US Oncology Business Unit. Prior to Amgen Elliot held roles with The Walt Disney Company and Arthur Andersen LLP.

Elliot holds a BS in Accounting from Indiana University, an MBA from the Anderson School of Management at UCLA and was a certified public accountant.